Amedisys, Inc. (NASDAQ:AMED) Shares Acquired by Verition Fund Management LLC

Verition Fund Management LLC lifted its stake in Amedisys, Inc. (NASDAQ:AMED) by 608.1% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 114,774 shares of the health services provider’s stock after purchasing an additional 98,565 shares during the quarter. Verition Fund Management LLC owned about 0.35% of Amedisys worth $11,077,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. KBC Group NV acquired a new position in Amedisys in the 3rd quarter valued at about $63,000. Innealta Capital LLC purchased a new stake in shares of Amedisys during the 2nd quarter valued at approximately $64,000. Signaturefd LLC lifted its holdings in Amedisys by 88.2% in the second quarter. Signaturefd LLC now owns 1,131 shares of the health services provider’s stock valued at $104,000 after acquiring an additional 530 shares during the last quarter. CWM LLC grew its position in Amedisys by 14.5% in the third quarter. CWM LLC now owns 2,190 shares of the health services provider’s stock worth $211,000 after acquiring an additional 277 shares during the period. Finally, Crossmark Global Holdings Inc. acquired a new stake in Amedisys during the third quarter worth $243,000. Hedge funds and other institutional investors own 94.36% of the company’s stock.

Amedisys Price Performance

NASDAQ:AMED opened at $91.41 on Friday. The company has a market capitalization of $2.99 billion, a P/E ratio of 36.27, a P/E/G ratio of 1.92 and a beta of 0.78. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.05. Amedisys, Inc. has a 52 week low of $88.81 and a 52 week high of $98.95. The stock’s fifty day moving average is $94.74 and its two-hundred day moving average is $95.62.

Amedisys (NASDAQ:AMED) last posted its earnings results on Wednesday, November 6th. The health services provider reported $1.00 EPS for the quarter, missing analysts’ consensus estimates of $1.19 by ($0.19). Amedisys had a net margin of 3.57% and a return on equity of 12.20%. The company had revenue of $587.67 million during the quarter, compared to analyst estimates of $586.75 million. During the same period in the previous year, the company earned $0.98 EPS. The company’s quarterly revenue was up 5.7% compared to the same quarter last year. Equities analysts expect that Amedisys, Inc. will post 4.55 EPS for the current year.

Amedisys Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.